Delivery Order SPE2DB20D2014-SPE2DB25FC72G
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $2,551.20 and ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,838.68 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price contract, which has no set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,618.27 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price, non-set-aside contract was delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order represents a standard pharmaceutical procurement mechanism under the federal medical supply chain. This award is issued...
- The Defense Logistics Agency awarded a $1,507.97 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,259.24 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a direct delivery order under the company's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $3,549.72 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with a completion date of September 4, 2025. This competitive, firm fixed-price delivery order was issued with no set-aside designation and represents a small-value pharmaceutical transaction supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,388.86 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract represents a firm fixed price arrangement for pharmaceutical supply. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,613.58 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with a completion deadline of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency has awarded a delivery order totaling $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This contract is not set-aside and was competitively awarded to the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on September 11, 2025, with a ceiling value of $3,388.86. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC72GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,397.66 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract, with no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting the federal medical supply chain for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's existing $999.99 billion IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The contract award demonstrates the company's continued capability to meet federal procurement requirements and supply essential pharmaceutical products to support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/12/25 |